,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'destinybreast04']
so exciting dara of the #destinybreast04 trial presented right now at #asco22 this result belongs to the remarkable moments in #breastcancer #therapy 
advocate, speaker, medical journalist, Founder: German Breast Cancer Ass. (Brustkrebs Deutschland e.V.), Director of the General Assembly ABC Global Alliance